Current stock page

Catalysts

ITCI Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - Specialty & GenericScore data as of Oct 31, 2026

ITCIIntra-Cellular Therapies, Inc.

Healthcare / Drug Manufacturers - Specialty & Generic

Low Priority

In Line With Peers

NeutralEdge 5/10
—

Latest quote

  • Momentum
    —
  • Value
    34
  • Quality
    60
  • Risk resilience
    82
  • Sentiment
    —
algovestiq.comScore data as of Oct 31, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 54/100

Momentum — and sentiment — before the next covered event.

Recent coverage
0 articles

Updated — · Sentiment not scored

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum —AIQ Edge 5/10 In Line With Peers
Beat rate
75%
6 of 8 reported periods
Average surprise
+8.1%
Across covered historical reports
Latest result
-100.0%
Feb 21, 2025
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Feb 21, 2025—-$0.08-$0.16-100.0%$193.4M$199.22M
Oct 30, 2024—-$0.18-$0.25-38.9%$194.01M$175.16M
Aug 7, 2024—-$0.18-$0.16+11.1%$157.88M$161.39M
May 7, 2024—-$0.31-$0.16+48.4%$141.41M$144.87M
Feb 22, 2024—-$0.44-$0.30+31.8%$135.67M$131.51M
Nov 2, 2023—-$0.59-$0.25+57.6%$136.9M$125.81M
Aug 3, 2023—-$0.62-$0.45+27.4%$106.65M$110.13M
May 4, 2023—-$0.63-$0.46+27.0%$91.98M$94.73M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
3
Buy
9
Hold
12-month analyst target
$132.00
— versus current price
Based on 1 analyst observations. Targets are estimates, not predictions.
No analyst target path in this snapshot.
Low target
$132.00
—
Average target
$132.00
—
High target
$132.00
—

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score—

Where event reaction would show up first.

AIQ score54/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
1
Average target
$132.00
Target range
$132.00 - $132.00
90-day revisions
0

News And Sentiment

Recent company coverage, scored where source sentiment is available.

No recent articles have a scored sentiment label.
Positive
0
Neutral
0
Negative
0

No recent company-specific news is available.

Open full news and sentiment

ITCI Catalysts FAQ

What are the next catalysts for ITCI stock?

ITCI's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move ITCI stock?

Upcoming events that could move ITCI include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could ITCI's next earnings report affect the stock?

ITCI's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive ITCI stock higher?

ITCI could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt ITCI stock?

ITCI could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.